On the same day Aphria shares slid more than 13% over delisting fears, the Leamington, Ontario-based company announced a deal to raise up to 92 million Canadian dollars ($73 million) in capital.
The new financing, announced Tuesday, came a day after the TMX Group, parent of the Toronto Stock Exchange and the TSX Venture Exchange, said that marijuana companies doing business in the United States could be delisted.
Aphria, trading on the TSE as APH, owns Liberty Health Sciences, which acquires and operates U.S.-based companies in the medical cannabis market.
In an interview with the Canadian Press, Aphria’s chief executive Vic
Aphria digs in over TMX dispute; inks deal for CA$92M in funding is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
The post Aphria digs in over TMX dispute; inks deal for CA$92M in funding appeared first on Marijuana News.